How much revenue does Acura Pharmaceuticals make?

Acura Pharmaceuticals reported $1.56 million in revenue for fiscal year 2021, down 56.2% from $3.57 million in fiscal year 2020.

What companies are similar to Acura Pharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Statera Biopharma, Inc. (STAB), FluoroPharma Medical, Inc. (FPMI), Entia Biosciences, Inc. (ERGO), CEN Biotech, Inc. (CENBF).

Acura Pharmaceuticals, Inc. (ACUR) Stock

About Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophe...

At a glance

Acura Pharmaceuticals reported revenue of $1.56 million for fiscal year 2021, down 56.2% from fiscal year 2020, and net income of -$879,000.

Figures from company filings; latest fiscal year ended December 31, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.